# CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD

> **NCT00641329** · PHASE3 · COMPLETED · sponsor: **Addrenex Pharmaceuticals, Inc.** · enrollment: 198 (actual)

## Conditions studied

- ADHD

## Interventions

- **DRUG:** CLONICEL (clonidine HCl sustained release)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00641329
- **Lead sponsor:** Addrenex Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 198 (ACTUAL)
- **Last updated:** 2010-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00641329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00641329, "CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00641329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*